Reaktion #57495

ord-a8cce7836032403e80e046db7d969d22

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    TemperaturThe reaction mixture was warmed to 55° C.
  2. 2
    workup.STIRRINGAfter stirring for 2 hours
  3. 3
    Sonstigethe reaction was evaporated in vacuo
  4. 4
    Sonstigethe residue was partitioned between dichloromethane and aqueous sodium hydrogen sulfate (1N)
  5. 5
    SonstigeAfter separating the phases
  6. 6
    Extraktionthe aqueous layer was extracted with dichloromethane
  7. 7
    TrocknenThe combined organic phases were dried over anhydrous magnesium sulfate
  8. 8
    Filtrationfiltered
  9. 9
    Sonstigeevaporated in vacuo
  10. 10
    SonstigeThe residue was purified on flash grade silica gel eluting with 3:2 ethyl acetate
  11. 11
    workup.ADDITIONFractions containing the product
  12. 12
    Sonstigeevaporated in vacuo
  13. 13
    Sonstigedried under high vacuum

Vorschrift

A mixture of (3R,3aS,6aR)hexahydrofuro[2,3-b]furan-3-yl (1S,2R)-1-benzyl-3-[(1-ethylpropoxy)amino]-2-hydroxypropylcarbamate (200 mg, 0.474 mmol), 4-benzyloxybenzenesulphonyl chloride (134 mg, 0.474 mmol), diisoproylethylamine (0.083 mL, 0.474 mmol) and dimethylaminopyridine (˜1 mg) in anhydrous tetrahydrofuran (3 mL) was stirred at ambient temperature over 16 hours under an Argon atmosphere. The reaction mixture was warmed to 55° C. and an additional quantity of dimethylaminopyridine (˜2 mg) was added. After stirring for 2 hours, the reaction was evaporated in vacuo and the residue was partitioned between dichloromethane and aqueous sodium hydrogen sulfate (1N). After separating the phases, the aqueous layer was extracted with dichloromethane. The combined organic phases were dried over anhydrous magnesium sulfate, filtered and evaporated in vacuo. The residue was purified on flash grade silica gel eluting with 3:2 ethyl acetate:hexane. Fractions containing the product were combined, evaporated in vacuo, and dried under high vacuum to provide (3R,3aS,6aR)hexahydrofuro[2,3-b]furan-3-yl (1S,2R)-1-benzyl-3-[{[4-(benzyloxy)phenyl]sulfonyl}(1-ethylpropoxy)amino]-2-hydroxypropylcarbamate (235 mg, 74%) as a foam. H1-NMR (chloroform-D3): 0.94 (m, 6H), 1.62 (m, 7H), 3.05 (m, 5H), 3.74 (m, 2H), 3.98 (m, 4H), 4.18 (m, 1H), 4.88 (d, 1H), 5.08 (m, 1H), 5.19 (s, 2H), 5.70 (d, 1H), 7.13 (d, 2H), 7.34 (m, 10H), 7.80 (d, 2H). MS(ESI): 691(M+Na).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07419967B2uspto-grants-2008_09